NCT00360230View on ClinicalTrials.gov

Partially-blind (Observer-blind) Study of Safety and Immunogenicity of Two Malaria Vaccines in Ghanaian Children

PHASE2CompletedINTERVENTIONAL
Enrollment

540

Participants

Timeline

Start Date

August 30, 2006

Primary Completion Date

August 25, 2007

Study Completion Date

May 30, 2008

Conditions
Malaria
Interventions
BIOLOGICAL

GSK Biologicals' candidate Plasmodium falciparum malaria vaccine 257049

2 different formulations are tested. For each formulation, 3 different dosing schedules are tested

BIOLOGICAL

Rabipur

3-dose intramuscular injection.

Trial Locations (2)

Unknown

GSK Investigational Site, Kintampo

GSK Investigational Site, Kumasi

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY